Table 5.
HIV care quality measures by physician specialization.
| General physician
|
Specialized physician
|
ARRa | 95% CI | |||
|---|---|---|---|---|---|---|
| N | % | N | % | |||
| CD4 cell count 90–210 days post-ART initiation (N =1323) | 320 | 36.4 | 176 | 39.7 | 0.88 | 0.74–1.04 |
| CD4 cell count 330–390 days post-ART initiation (N =1057) | 131 | 18.4 | 67 | 19.5 | 0.97 | 0.71–1.34 |
| Clinician visit 3 of 4 quarters post-ART initiation (N =1057) | 631 | 88.5 | 295 | 85.8 | 1.01 | 0.97–1.05 |
| Optimal 180-day antiretroviral drug adherence (≥90% antiretroviral drug pick-up) (N =1323) | 689 | 78.3 | 330 | 74.5 | 1.02 | 0.94–1.11 |
| Loss to follow-up (N =1799) | 137 | 11.2 | 87 | 15.1 | 1.06 | 0.75–1.48 |
ARR, Adjusted risk ratio or adjusted hazard ratio for loss to follow-up; ART, antiretroviral therapy; CI, confidence interval; NPC, non-physician clinician.
a
Adjusted for clinic and years of patient education. Risk ratios and confidence intervals estimated using generalized linear models for the binomial family, or Cox proportional hazards regression for loss to follow-up.